Detalles de la búsqueda
1.
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA).
Ann Rheum Dis
; 75(1): 68-74, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056119
2.
Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
Clin Exp Rheumatol
; 34(4): 625-33, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27087059
3.
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
Ann Rheum Dis
; 73(1): 69-74, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23904473
4.
Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis.
Int J Clin Pharmacol Ther
; 52(1): 27-38, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24161161
5.
Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects.
Int J Clin Pharmacol Ther
; 51(6): 443-55, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23547848
6.
Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20.
Int J Clin Pharmacol Ther
; 51(7): 537-48, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23547849
7.
Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis.
Int J Clin Pharmacol Ther
; 51(8): 620-30, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782588
8.
Evidence of a drug-drug interaction linked to inhibition of ester hydrolysis by orlistat.
J Cardiovasc Pharmacol
; 60(4): 390-6, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22820896
9.
Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects.
Antimicrob Agents Chemother
; 55(2): 680-7, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135186
10.
A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study.
J Antimicrob Chemother
; 62(6): 1374-8, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18782780
11.
Adherence to enfuvirtide and its impact on treatment efficacy.
AIDS Res Hum Retroviruses
; 24(2): 141-8, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18240965
12.
Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients.
HIV Clin Trials
; 9(2): 73-82, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18474492
13.
Switching from a toxicity-causing antiretroviral to enfuvirtide in patients with HIV: the SWITCH TOX study.
HIV Clin Trials
; 9(6): 375-86, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19203903
14.
Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients.
Pediatr Infect Dis J
; 26(9): 799-805, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17721374
15.
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS Patient Care STDS
; 21(8): 533-43, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17711378
16.
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
J Clin Pharmacol
; 57(4): 459-468, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599663
17.
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Arthritis Care Res (Hoboken)
; 66(11): 1653-61, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942540
18.
Design of the tocilizumab in giant cell arteritis trial.
Int J Rheumatol
; 2013: 912562, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23653652
19.
Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?
Clin Pharmacokinet
; 52(4): 255-65, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23400900
20.
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
Bone
; 46(3): 660-5, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19909829